Increased Atherothrombotic Burden in Patients with Diabetes Mellitus and Acute Coronary Syndrome: A Review of Antiplatelet Therapy

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="1"><hr/></td></tr><tr><td align="">Impaired TF production.</td></tr><tr><td align="">Elevated F VII:c levels.</td></tr><tr><td align="">Increased thrombin generation.</td></tr><tr><td align="">High levels of IL-6 and fibrinogen.</td></tr><tr><td align=""> Impaired fibrinolysis as a result of elevated PAI-1 levels.</td></tr><tr class="table-tr"><td colspan="1"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Coagulation and Fibrinolysis Dysregulation in Diabetes Mellitus.

Cardiology Research and Practice

tab2

Table 2

Table 2: Increased Atherothrombotic Burden in Patients with Diabetes Mellitus and Acute Coronary Syndrome: A Review of Antiplatelet Therapy 